©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 21, 2019; 25(27): 3484-3502
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3484
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3484
Colorectal peritoneal metastases: Optimal management review
Juan Manuel Sánchez-Hidalgo, Lidia Rodríguez-Ortiz, Álvaro Arjona-Sánchez, Sebastián Rufián-Peña, Ángela Casado-Adam, Antonio Cosano-Álvarez, Javier Briceño-Delgado, Department of General and Digestive Surgery, Reina Sofia University Hospital, Cordoba 14004, Spain
Author contributions: Sánchez-Hidalgo JM, Arjona-Sánchez A and Rodríguez-Ortiz L contributed to the conception and design of the review; Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Casado-Adam A and Cosano-Álvarez A contributed to literature review and analysis; Sánchez-Hidalgo JM, Rodríguez-Ortiz L wrote the article; Sanchez-Hidalgo JM, Rodríguez-Ortiz L and Arjona-Sánchez A contributed to drafting and critical revision and editing; Sánchez-Hidalgo JM, Rufian-Peña S and Briceño-Delgado J approved the final version.
Conflict-of-interest statement: Any author has any potential conflicts of interest to declare. No financial support was received for this review.
Corresponding author: Juan Manuel Sánchez-Hidalgo, MD, PhD, Doctor, Surgical Oncologist, Department of General and Digestive Surgery, Reina Sofia University Hospital, Avda. Menéndez Pidal s/n, Cordoba 14004, Spain. juanmanuelsanchezhidalgo@hotmail.com
Telephone: +34-957-010000
Received: February 27, 2019
Peer-review started: March 1, 2019
First decision: April 5, 2019
Revised: May 20, 2019
Accepted: June 22, 2019
Article in press: June 23, 2019
Published online: July 21, 2019
Processing time: 142 Days and 14 Hours
Peer-review started: March 1, 2019
First decision: April 5, 2019
Revised: May 20, 2019
Accepted: June 22, 2019
Article in press: June 23, 2019
Published online: July 21, 2019
Processing time: 142 Days and 14 Hours
Core Tip
Core tip: Patients with peritoneal metastases from colorectal cancer have classically been associated with limited survival and treated only with palliative surgery and systemic support. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, often combined with systemic treatment, are increasingly performed with a curative intent for well-selected patients. Recent data suggests an important improvement of overall and disease-free survival for these patients. This article aims to review the state of art for the management of peritoneal metastases from colorectal origin and to confine the latest experts’ consensus and future directives.